HCD Sell side diminishing, buyers lurking and ready to pay up (wards). The Santos collaboration is a huge deal. I am thinking that the top could blow off here. And there's 3 cents...,as foretold.
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status
